Business
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. LOS ANGELES, CA - July 8, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage bio...
About this update from Nrx Pharmaceuticals, Inc.
[{"type":"text","content":"This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community.","length":145,"tagName":"p"},{"type":"text","content":"LOS ANGELES, CA - July 8, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49% stake in Cohen and Associates, LLC, a respected neuropsychiatry clinic based in western Florida (https://ibn.fm/geIxF).","length":414,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE Therapeutics, is expected to be immediately accretive to revenue and EBITDA.","length":188,"tagName":"p"}]},{"val":[{"type":"text","content":"Cohen, serving the Sarasota-Bradenton area in Florida, specializes in treatments, including ketamine and TMS, for mood disorders, PTSD, and suicidal depression.","length":160,"tagName":"p"}]},{"val":[{"type":"text","content":"HOPE Therapeutics is expanding toward a target of 30 clinics with a $100 million run rate by the end of 2025.","length":109,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":457,"olType":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":"Investor Brand Network","className":"","disableSlideshowImg":false,"size":{"original":{"width":1400,"height":800,"url":"https://media.zenfs.com/en/newsmediawire_165/8e296eb231ad1274d077ef906284c7b9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8BRt8MpDI9XVqOjLqL2Kbg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0OTtjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/8e296eb231ad1274d077ef906284c7b9","width":960,"height":549},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/PZu23rr6AUQEE3Kmbijnhw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMzcyO2NmPXdlYnA-/https://media.zenfs.com/en/newsmediawire_165/8e296eb231ad1274d077ef906284c7b9","width":1200,"height":686}}},{"type":"text","content":"The agreement, announced on June 26, positions Cohen as a foundational clinic in the Sarasota-Bradenton region for HOPE's growing network. Cohen and Associates, led by Dr. Rebecca Cohen, offers a comp...